Protocol NRG-BR009, A Phase III Adjuvant Trial Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression plus Endocrine Therapy in Premenopausal Patients with pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score less than or equal to 25 (OFSET)

Is this Study for You?

Let's Get Started!




Cherry Creek Medical Center
Highlands Ranch Hospital
Lone Tree Medical Center
Memorial Hospital Central
Memorial Hospital North
University of Colorado Hospital

Principal Investigator
Photograph of Virginia Borges

Virginia Borges

Study ID

Protocol Number: 23-2461

More information available at NCT05879926

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers